Morris RT - Search Results

1

Radiation-associated endometrial cancer.

Kumar S, Shah JP, Bryant CS, Seward S, Ali-Fehmi R, Morris RT, Malone JM Jr. Kumar S, et al. Among authors: morris rt. Obstet Gynecol. 2009 Feb;113(2 Pt 1):319-25. doi: 10.1097/AOG.0b013e3181954c5b. Obstet Gynecol. 2009. PMID: 19155901

2

Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells.

Munkarah AR, Morris R, Baumann P, Deppe G, Malone J, Diamond MP, Saed GM. Munkarah AR, et al. J Soc Gynecol Investig. 2002 May-Jun;9(3):168-73. J Soc Gynecol Investig. 2002. PMID: 12009392

3

Upper extremity deep vein thrombosis associated with indwelling peripheral venous catheters in gynecology oncology patients.

Schimp VL, Munkarah AR, Morris RT, Deppe G, Malone J Jr. Schimp VL, et al. Among authors: morris rt. Gynecol Oncol. 2003 May;89(2):301-5. doi: 10.1016/s0090-8258(03)00074-x. Gynecol Oncol. 2003. PMID: 12713995

4

The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.

Ali-Fehmi R, Che M, Khalifeh I, Malone JM, Morris R, Lawrence WD, Munkarah AR. Ali-Fehmi R, et al. Cancer. 2003 Oct 1;98(7):1423-9. doi: 10.1002/cncr.11650. Cancer. 2003. PMID: 14508829 Free article.

5

Expression of Cox-2, CD34, Bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma.

Khalifeh I, Munkarah AR, Lonardo F, Malone JM, Morris R, Lawrence WD, Ali-Fehmi R. Khalifeh I, et al. Int J Gynecol Pathol. 2004 Apr;23(2):162-9. doi: 10.1097/00004347-200404000-00011. Int J Gynecol Pathol. 2004. PMID: 15084845

6

Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT).

Barnholtz-Sloan JS, Morris R, Malone JM Jr, Munkarah AR. Barnholtz-Sloan JS, et al. Gynecol Oncol. 2004 May;93(2):506-12. doi: 10.1016/j.ygyno.2004.02.016. Gynecol Oncol. 2004. PMID: 15099970

7

Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis.

Saad A, Lo SS, Han I, Keole S, Lee CP, Tekyi-Mensah S, Munkarah A, Malone J, Morris R, Deppe G. Saad A, et al. Am J Clin Oncol. 2004 Jun;27(3):256-63. doi: 10.1097/01.coc.0000092564.16409.cd. Am J Clin Oncol. 2004. PMID: 15170144

8

Retrospective analysis of weekly topotecan as salvage therapy in relapsed ovarian cancer.

Bhoola SM, Coleman RL, Herzog T, Morris R, Bryant C, Estes JM, Alvarez RD. Bhoola SM, et al. Gynecol Oncol. 2004 Dec;95(3):564-9. doi: 10.1016/j.ygyno.2004.08.026. Gynecol Oncol. 2004. PMID: 15581964

9

Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival.

Ali-Fehmi R, Morris RT, Bandyopadhyay S, Che M, Schimp V, Malone JM Jr, Munkarah AR. Ali-Fehmi R, et al. Among authors: morris rt. Am J Obstet Gynecol. 2005 Mar;192(3):819-25. doi: 10.1016/j.ajog.2004.10.587. Am J Obstet Gynecol. 2005. PMID: 15746677

10

The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma.

Khalifeh I, Munkarah AR, Schimp V, Morris R, Lawrence WD, Ali-Fehmi R. Khalifeh I, et al. Int J Gynecol Pathol. 2005 Jul;24(3):228-34. doi: 10.1097/01.pgp.0000164599.26969.8a. Int J Gynecol Pathol. 2005. PMID: 15968197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters